title: Does metabolic syndrome increase erectile dysfunction and lower urinary tract symptoms.
abstract: OBJECTIVE
  To evaluate the impact of metabolic syndrome (MS) on erectile dysfunction (ED) and lower urinary tract symptoms (LUTS).
  
  
  METHODS
  We included patients who had presented at the urology outpatients with LUTS or ED complaints and at the endocrinology outpatients for diabetes between May 2012 and April 2013. MS was present in 50 of the 107 patients (42.7%). The blood pressure, fasting blood sugar, serum lipid profile, triglyceride, total cholesterol, body mass index (BMI) and total prostate specific antigen (PSA) values were recorded. The international prostate symptom score (IPSS), quality of life score and international erectile function index (IIEF-5) values were determined for the patients. All patients also underwent uroflowmetry together with prostate volume and residual urine volume measurement.
  
  
  RESULTS
  There was a significant negative correlation between the IPSS and IIEF scores of the patients (P &lt; .001, r = -0.42). There was no significant difference regarding IPSS scores between patients with and without MS (P = .6), while the IIEF-5 scores were significantly lower in the MS group (P = .03).
  
  
  CONCLUSIONS
  We found that metabolic syndrome did not significantly affect LUTS but could significantly contribute to ED. We therefore feel patients presenting with ED complaints should also be carefully evaluated for MS.&nbsp;
authors.affiliation: Department of Urology, Sevket Yilmaz Training and Research Hospital, Bursa, Turkey.
authors.forename: Soner
authors.initials: S
authors.lastname: Coban
authors.affiliation: Department of Endocrinology and Metablism, Sevket Yilmaz Training and Research Hospital, Bursa, Turkey.
authors.forename: Soner
authors.initials: S
authors.lastname: Cander
authors.affiliation: Department of Endocrinology and Metablism, Sevket Yilmaz Training and Research Hospital, Bursa, Turkey.
authors.forename: Mehmet Sakir
authors.initials: MS
authors.lastname: Altuner
authors.affiliation: Department of Urology, School of Medicine, Afyon Kocatepe University, Afyon karahisar,Turkey. drkeles@hotmail.com.
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Keles
authors.affiliation: Department of Endocrinology and Metablism, Sevket Yilmaz Training and Research Hospital, Bursa, Turkey.
authors.forename: Ozen Oz
authors.initials: OO
authors.lastname: Gul
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D048909:Diabetes Complications / Q000503:physiopathology; D050171:Dyslipidemias / Q000150:complications / Q000503:physiopathology; D007172:Erectile Dysfunction / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D005215:Fasting; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D008075:Lipoproteins, HDL / Q000097:blood; D059411:Lower Urinary Tract Symptoms / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000503:physiopathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011788:Quality of Life; D012720:Severity of Illness Index; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D008075:Lipoproteins, HDL; D014280:Triglycerides; D002784:Cholesterol; D017430:Prostate-Specific Antigen